Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology

Paul H. Frankel, Vincent Chung, Yan Xing, Jeff Longmate, Susan Groshen, Edward M. Newman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences